16-67908795-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006742.3(PSKH1):c.46G>A(p.Val16Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000876 in 1,610,256 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006742.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PSKH1 | NM_006742.3 | c.46G>A | p.Val16Ile | missense_variant | 2/3 | ENST00000291041.6 | NP_006733.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PSKH1 | ENST00000291041.6 | c.46G>A | p.Val16Ile | missense_variant | 2/3 | 1 | NM_006742.3 | ENSP00000291041.4 | ||
PSKH1 | ENST00000570631.5 | c.46G>A | p.Val16Ile | missense_variant | 2/2 | 1 | ENSP00000482880.1 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000157 AC: 39AN: 248400Hom.: 2 AF XY: 0.000157 AC XY: 21AN XY: 134116
GnomAD4 exome AF: 0.0000885 AC: 129AN: 1458042Hom.: 1 Cov.: 31 AF XY: 0.0000924 AC XY: 67AN XY: 724906
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152214Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 16, 2024 | The c.46G>A (p.V16I) alteration is located in exon 2 (coding exon 1) of the PSKH1 gene. This alteration results from a G to A substitution at nucleotide position 46, causing the valine (V) at amino acid position 16 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at